Amyloid-β25-35, an amyloid-β1-42 surrogate, and proinflammatory cytokines stimulate VEGF-A secretion by cultured, early passage, normoxic adult human cerebral astrocytes

Journal of Alzheimer's Disease

Volumn 21, Issue 3, 2010, Pages 915-926

  Chiarini, Anna ^a   Whitfield, James ^b   Bonafini, Clara ^a   Chakravarthy, Balu ^b   Armato, Ubaldo ^a   Dal Prà, Ilaria ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

Alzheimer's disease; amyloid peptides; cerebrovascular angiopathy; HIF 1; normal adult human astrocytes; proinflammatory cytokines; VEGF A

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; AMYLOID BETA PROTEIN[25-35]; CYTOKINE; GAMMA INTERFERON; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 1BETA; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN A;

ADULT; ARTICLE; ASTROCYTE; CELL CULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; HIPPOCAMPUS; HUMAN; HUMAN CELL; MALE; MICROGLIA; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN SECRETION; PROTEIN TRANSPORT; RNA SYNTHESIS;

EID: 77957272288     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2010-100471     Document Type: Article

References (56)

1. Suh H, Deng W, Gage FH (2009) Signaling in adult neurogenesis. Annu Rev Cell Dev Biol 25, 253275.
2. Pogue AI, Lukiw WJ (2004) Angiogenic signaling in Alzheimer's disease. Neuroreport 15, 15071510.
3. Thirumangalakudi L, Samany PG,OwosoA,Wiskar B, Grammas P (2006) Angiogenic proteins are expressed by brain blood vessels in Alzheimer's disease. J Alzheimers Dis 10, 111118. (Pubitemid 44401371)
4. Kalaria RN, Cohen DL Premkumar DR, Nag S, LaManna JC, Lust WD (1998) Vascular endothelial growth factor in Alzheimer's disease and experimental cerebral ischemia. Brain Res Mol Brain Res 62, 101105. (Pubitemid 29023185)
5. Zand L, Ryu JK, McLarnon JG (2005) Induction of angiogenesis in the betaamyloid peptideinjected rat hippocampus. Neuroreport 16, 129132. (Pubitemid 40250384)
6. Frede S, Berchner Pfannschmidt U, Fandrey J (2007) Regulation of hypoxiainducible factors during inflammation. Methods Enzymol 435, 405419.
7. Ryu JK, McLarmon JG (2009) A leaky bloodbrain barrier, fibrinogen infiltration and microglial reactivity in inflamed Alzheimer's disease brain. J Cell Mol Med Jul 13, 29112925.
8. Park SY, Chae CB (2007) Toxic levels of amyloid beta peptide do not induce VEGF synthesis. Mol Cells 24, 6975.
9. Soucek T, Cumming R, Dargusch R, Maher P, Schubert D (2003) The regulation of glucose metabolism by HIF1 mediates a neuroprotective response to amyloid beta peptide. Neuron 39, 4356. (Pubitemid 36830947)
10. BrahimiHorn MC, Pouysségur J (2007) Oxygen, a source of life and stress. FEBS Lett 581, 35823591. (Pubitemid 47081011)
11. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD, Semenza GL (1996) Activation of vascular endothelial growth factor gene transcription by hypoxiainducible factor 1. Mol Cell Biol 16, 46044613. (Pubitemid 26272112)
12. Huang LE, Bunn HF (2003) O2 sensing, HIF, and regulation of gene expression. J Biol Chem 278, 1957578.
13. Ke Q, Costa M (2006) Hypoxiainducible factor1 (HIF1). Mol Pharmacol 70, 14691480.
14. Koh MY, Darnay BG, Powis G (2008) Hypoxiaassociated factor, a novel E3ubiquitin ligase, binds and ubiquitinates hypoxiainducible factor1-, leading to its oxygenindependent degradation. Mol Cell Biol 28, 70817095.
15. Pagés G, Pouysségur J (2005) Transcriptional regulation of the vascular endothelial growth factor gene - a concert of activating factors. Cardiovasc Res 65, 564573. (Pubitemid 40138977)
16. Ruiz De Almodovar C, Lambrechts D, Mazzone M, Carmeliet P (2009) Role and therapeutic potential of VEGF in the nervous system. Physiol Rev 89, 607648.
17. Semenza GL (1999) Regulation of mammalian O2 homeostasis by hypoxiainducible factor 1. Annu Rev Cell Dev Biol 15, 551578.
18. Semenza GL (2002) Signal transduction to hypoxiainducible factor 1. Biochem Pharmacol 64, 993998.
19. Kaminsky YG, Marlatt MW, Smith MA, Kosenko EA (2010) Subcellular and metabolic examination of amyloidbeta peptides in Alzheimer disease pathogenesis: evidence for Abeta(25-35). Exp Neurol 221, 2637.
20. Dehne N, Brüne B (2009) HIF1 in the inflammatory microenvironment. Exp Cell Res 315, 17911797.
21. Rogers J, CooperNR,Webster S, Schultz J,McGeer PL, Styres SD, Civin WH, Brachova L, Bradt B, Ward P, Lieberburg I (1992) Complement activation by beta amyloid inAlzheimer's disease. Proc Natl Acad Sci U S A 89, 1001610020.
22. McLarnon JG, Ryu JK (2008) Relevance of A-1-42 intrahippocampal injection as an animal model of inflamed Alzheimer's disease brain. Curr Alzheimer Res 5, 475480.
23. Ryu JK, Cho T, Choi HB, Wang YT, McLarnon JG (2009) Microglial VEGF receptor response is an integral chemotactic component in Alzheimer's disease pathology. J Neurosci 29, 313.
24. Chiarini A, Dal Pra I, Gottardo R, Bortolotti F, Whitfield JF, Armato U (2005) BH4 (tetrahydrobiopterin)dependent activation, but not the expression, of inducible NOS (nitric oxide synthase)2 in proinflammatory cytokinestimulated, cultured normal human astrocytes is mediated by MEKERK kinases. J Cell Biochem 94,731743. (Pubitemid 41420272)
25. Chiarini A, Dal Pra I, Menapace L, Pacchiana R, Whitfield JF, Armato U (2005) Soluble amyloid beta peptide and myelin basic protein strongly stimulate, alone and in synergism with combined proinflammatory cytokines, the expression of func tional nitric oxide synthase2 in normal adult human astrocytes. Int J Mol Med 16, 801807.
26. Dal Pra I, Chiarini A, Nemeth EF, Armato U, Whitfield JF (2005) Roles of Ca2+ and the Ca2+sensing receptor (CASR) in the expression of inducible NOS (nitric oxide synthase)2 and its BH4 (tetrahydrobiopterin)dependent activation in cytokinestimulated adult human astrocytes. J Cell Biochem 96, 428438 (Pubitemid 41437873)
27. Chiarini A,Armato U, Pacchiana R, Dal Pra I (2009) Proteomic analysis of GTP cyclohydrolase 1 multiprotein complexes in cultured normal adult human astrocytes under both basal and cytokineactivated conditions. Proteomics 9, 18501860.
28. Bausero P, BenMahdi M, Mazucatelli J, Bloy C, PerrotApplanatM( 2000) Vascular endothelial growth factor is modulated in vascular muscle cells by estradiol, tamoxifen, and hypoxia. Am J Physiol Heart Circ Physiol 279, H2033H2042.
29. Bradford MM (1976) A rapid and sensitive method for the quantitation ofmicrogram quantities protein utilizing the principle of proteindye binding. Anal Biochem 72, 248254.
30. Houck KA, Ferrara N,Winer J, Cachianes G, Li B, Leung DW (1991). The vascular endothelial growth factor family: Identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol 5, 18061814.
31. Whittle C, Gillespie K, Harrison R, Mathieson PW, Harper SJ (1999) Heterogeneous vascular endothelial growth factor (VEGF) isoform mRNA and receptor mRNA expression in human glomeruli, and the identification of VEGF148 mRNA, a novel truncated splice variant. Clin Sci (Lond) 97, 303312. (Pubitemid 29425324)
32. Semenza GL (2003) Angiogenesis in ischemic and neoplastic disorders. Annu Rev Med 54, 1728.
33. Schubert D, Soucek T, Blouw B (2009) The induction of HIF1 reduces astrocyte activation by amyloid beta peptide. Eur J Neurosci 29, 13231334.
34. Carmeliet P, (2003) Blood vessels and nerves: Common signals, pathways and diseases. Nat Rev Genet 4, 71020. (Pubitemid 37046138)
35. Kalaria RN (1997) Cerebrovascular degeneration is related to amyloid beta protein deposition in Alzheimer's disease. Ann N Y Acad Sci 826, 263271. (Pubitemid 27478048)
36. Kalaria RN (2002) Small vessel disease and Alzheimer's dementia: Pathological considerations. Cerebrovasc Dis 13, 4852. (Pubitemid 34233909)
37. Argaw AT, Zhang Y, Snyder BJ, Zhao ML, Kopp N, Lee SC, Raine CS, Brosman CF, John GR (2006) IL1- regulates bloodbrain barrier permeability via reactivation of the hypoxiaangiogenesis program. J Immunol 177, 55745584.
38. Chiarini A, Dal Pra I, Whitfield JF, Armato U (2006) The killing of neurons by betaamyloid peptides, prions, and proinflammatory cytokines. Ital J Anat Embryol 111, 221246.
39. Dal Pra I, Chiarini A, Pacchiana R, Chakravarthy B,Whitfield JF, Armato U (2008) Emerging concepts of how-amyloid proteins and proinflammatory cytokines might collaborate to produce an 'Alzheimer brain'. Mol Med Rep 1, 173178.
40. Brüne B, Zhou J (2007) Hypoxiainducible factor1- under the control of nitric oxide. Methods Enzymol 435, 463478.
41. Kasuno K, Takabuchi S, Fukuda K, KizakaKondoh S, Yodoi J, Adachi T, Semenza GL, Hirota K (2004) Nitric oxide induces hypoxiainducible factor1 activation that is dependent on MAPK and phosphatidylinositol 3kinase signaling. J Biol Chem 279, 25502558. (Pubitemid 38114240)
42. Kimura H, Weisz A, Kurashima Y, Hashimoto K, Ogura T, D'Acquisto F,AddeoR,MakuuchiM, EsumiH(2000)Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: Control of hypoxiainducible factor1 activity by nitric oxide. Blood 95, 189197. (Pubitemid 30017242)
43. Kimura H, Weisz A, Ogura T, Hitomi Y, Kurashima Y, Hashimoto K, D'Acquisto F, Makuuchi M, Esumi H (2001) Identification of hypoxiainducible factor 1 ancillary sequence and its function in vascular endothelial growth factor gene induction by hypoxia and nitric oxide. J Biol Chem 276, 22922298. (Pubitemid 32109715)
44. Jakovcevic D and Harder DR (2007) Role of astrocytes in matching blood flow to neuronal activity. Curr Top Dev Biol 79, 7597.
45. Leybaert L, De Bock M, Van Moorhem M, Decrock E, De Vuyst E (2007) Neurobarrier coupling in the brain: Adjusting glucose entry with demand. J Neurosci Res 85, 32133220. (Pubitemid 350058510)
46. Bell RD, Zlokovic BV (2009) Neurovascular mechanisms and bloodbrain barrier disorder in Alzheimer's disease. Acta Neuropathol 118, 103113.
47. Zlokovic BV (2008) The bloodbrain barrier in health and chronic neurodegenerative disorders. Neuron 57, 178201.
48. Farkas E, Luiten PG (2001) Cerebral microvascular pathology in aging andAlzheimer's disease. ProgNeurobiol 64, 575611. (Pubitemid 32304447)
49. Stopa EG, Butala P, Salloway S, Johanson CE, Gonzalez L, Tavares R, Hovanesian V, Hulette CM, Vitek MP, Cohen RA (2008) Cerebral cortical arteriolar angiopathy, vascular-amyloid, smooth muscle actin, Braak stage, and APOE genotype. Stroke 39, 814821.
50. Thal DR, Griffin WS, Braak H (2008) Parenchymal and vascular A-deposition and its effects on the degeneration of neurons and cognition in Alzheimer's disease. J Cell Mol Med 12, 18481862.
51. Zachary I (2005) Neuroprotective role of vascular endothelial growth factor: signalling mechanisms, biological function, and therapeutic potential. Neurosignals 14, 207221. (Pubitemid 41661355)
52. Wu X, Jelinek DF (2005) AMizing BCL6. Nat Immunol 6, 964966.
53. Tang TT, Dowbenko D, Jackson A, Toney L, Lewin DA, Dent AL, Lasky LA (2002) The forkhead transcription factor AFX activates apoptosis by induction of the BCL6 transcriptional repressor. J Biol Chem 277, 1425514265. (Pubitemid 34968040)
54. Whitfield JF, Chakravarthy BK (2009) The neuronal primary cilium: Driver of neurogenesis and memory formation in the hippocampal dentate gyrus? Cell Signal 21, 13511355.
55. Schänzer A, Wachs FP, Wilhelm D, Acker T, CooperKuhn C, Beck H, Winkler J, Aigner L, Plate KH, Kuhn HG (2004) Direct stimulation of adult neural stem cells in vitro and neurogenesis in vivo by vascular endothelial growth factor. Brain Pathol 14, 237248. (Pubitemid 39095985)
56. Waldau B, Shetty AK. Behavior of neural stem cells in the Alzheimer brain. (2008) Cell Mol Life Sci 65, 23722384.